Fibroblastic reticula cells can organize T cells in the fight against lung cancer
Institute of Immunobiology-led research has made a significant breakthrough in understanding how the body combats lung cancer ...
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus
All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...
News Medical on MSN12d
Scientists identify drug-resistant bone marrow cells linked to poor outcomes in fast-growing leukemia
In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...
News Medical9d
Fibroblastic reticular cells power immune defenses in lung cancer
Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to ...
Deccan Chronicle1d
Rescue efforts uncover hidden cells in Syria's infamous Sednaya prison
On the outskirts of Sednaya prison, known as Syria’s “human slaughterhouse,” a hidden underground complex was uncovered, ...
Fate Therapeutics presents new data from FT819 study
Fate Therapeutics (FATE) presented new clinical and translational data from the company’s FT819 Phase 1 Autoimmunity study for ...
Morningstar12d
Fate Therapeutics Announces Leadership Transition
About Fate Therapeutics’ iPSC Product Platform Human induced pluripotent stem cells (iPSCs) possess the unique dual properties of unlimited self-renewal and differentiation potential into all ...